Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Goldman Sachs FICC Revenue Falls 10% Amid Iran War Market Volatility 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
DEEPX Partners with Hyundai to Power Next-Gen AI Robots Ahead of IPO 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Japan Opens Arms Export Floodgates: New Policy Draws Global Defense Interest 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
PLAINSBORO, N.J., April 06, 2016 -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) will release its first quarter 2016 financial results on Wednesday, April 27, 2016. The company has scheduled a conference call for 8:30 AM ET the same day to discuss the results.
Integra’s senior management team will host the conference call, which will be open to all listeners. There will also be a question and answer session following the prepared remarks.
Access to the live call is available by dialing (800) 344-6698 and using the passcode 9747569. The call can also be accessed through a webcast via a link provided on the Investor Relations homepage of Integra's website at www.integralife.com. Access to the replay is available through May 2, 2016 by dialing (719) 457-0820 and using the passcode 9747569. The webcast will also be archived on the website.
Integra LifeSciences, a world leader in medical technology, is dedicated to limiting uncertainty for caregivers, so they can concentrate on providing the best patient care. Integra offers innovative solutions, including leading regenerative technologies, in specialty surgical solutions and orthopedics and tissue technologies. For more information, please visit www.integralife.com
Contacts: Integra LifeSciences Holdings Corporation Investor Relations: Angela Steinway (609) 936-2268 [email protected] Michael Beaulieu (609) 750-2827 [email protected]
